AU2003241985A1 - Dna inducing cancer cell-specific expression and cancer cell-specific expression vector - Google Patents

Dna inducing cancer cell-specific expression and cancer cell-specific expression vector

Info

Publication number
AU2003241985A1
AU2003241985A1 AU2003241985A AU2003241985A AU2003241985A1 AU 2003241985 A1 AU2003241985 A1 AU 2003241985A1 AU 2003241985 A AU2003241985 A AU 2003241985A AU 2003241985 A AU2003241985 A AU 2003241985A AU 2003241985 A1 AU2003241985 A1 AU 2003241985A1
Authority
AU
Australia
Prior art keywords
cancer cell
specific expression
expression vector
dna inducing
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241985A
Inventor
Kohji Egawa
Eri Kuwada
Katsuo Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinet Co Ltd
Original Assignee
Medinet Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinet Co Ltd filed Critical Medinet Co Ltd
Publication of AU2003241985A1 publication Critical patent/AU2003241985A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003241985A 2002-05-31 2003-05-30 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector Abandoned AU2003241985A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002160358 2002-05-31
JP2002-160358 2002-05-31
PCT/JP2003/006844 WO2003102186A1 (en) 2002-05-31 2003-05-30 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector

Publications (1)

Publication Number Publication Date
AU2003241985A1 true AU2003241985A1 (en) 2003-12-19

Family

ID=29706542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241985A Abandoned AU2003241985A1 (en) 2002-05-31 2003-05-30 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector

Country Status (3)

Country Link
JP (1) JPWO2003102186A1 (en)
AU (1) AU2003241985A1 (en)
WO (1) WO2003102186A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2266846A1 (en) * 1996-09-25 1998-04-02 Mcgill University Hex ii tumor-specific promoter and uses thereof in cancer therapy
US6087164A (en) * 1997-10-03 2000-07-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for inducing tumor-specific cytotoxicity
WO2001023004A1 (en) * 1999-09-30 2001-04-05 The Trustees Of The University Of Pennsylvania Replication selective adenoviruses for use in cancer therapy
WO2001090344A1 (en) * 2000-05-25 2001-11-29 University Of Virginia Patent Foundation β-HCG PROMOTER BASED TUMOR-RESTRICTIVE GENE EXPRESSION FOR CANCER GENE THERAPY

Also Published As

Publication number Publication date
JPWO2003102186A1 (en) 2005-09-29
WO2003102186A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AU2003215460A1 (en) Cancer associated protein kinases and their uses
AU2002306374A1 (en) Genes with ES cell-specific expression
AU2003239129A1 (en) Methods and compositions for dna manipulation
EP1403366A4 (en) Genes with es cell-specific expression
GB2408507B (en) Chimeric MHC protein and oligomer thereof for specific targeting
AU2003220387A1 (en) Gene amplification in cancer
PL376971A1 (en) Amplified genes involved in cancer
AU2003212162A1 (en) Cancer associated protein phosphatases and their uses
AU2003227861A1 (en) Protein involved in cancer
AU2003212826A1 (en) Cancer genes
AU2003241985A1 (en) Dna inducing cancer cell-specific expression and cancer cell-specific expression vector
AU2003235096A1 (en) Novel protein and dna thereof
AU2003299491A1 (en) Fagopyritol synthase genes and uses thereof
AU2002259005A1 (en) Compositions and methods for inducing cancer cell death
AU2003275946A1 (en) Gene expression in biological conditions
AU2001288940A1 (en) Gene and sequence variation associated with cancer
AU2002953015A0 (en) Modified lacz gene
AU2002240921A1 (en) Medane genes and proteins
AU2003258658A1 (en) Improved dna and proteins
EP1642586A4 (en) Cell-containing preparations
EP1702072A4 (en) Genetic therapy and genetic modification using neocentromeric minichromosomes
AU2003262080A1 (en) Novel protein and dna thereof
EP1589101A4 (en) Novel protein and its gene
AU2003241762A1 (en) Dna shuflling
AU2003262815A1 (en) New tumor suppressor genes and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase